September 12, 2011

While settlements constitute the most prominent patent-related issue for generic drugs, two others have cropped up this year as well.


September 12, 2011

At press time, Hurricane Irene was slowly barreling toward the East Coast and threatening the area with a deluge that prompted cities to shut down and had store shelves wiped clean.


September 1, 2011

Branded drugs sold under their generic names at a reduced price can reduce retail and wholesale drug prices, according to a new report by the Federal Trade Commission.

June 21, 2011

Watson subsidiary Watson Labs is seeking approval for a drug designed to treat symptomatic benign prostatic hyperplasia in men with an enlarged prostate.

May 20, 2011

Sandoz is looking to market a generic version of a Shire drug for treating attention deficit hyperactivity disorder.

April 21, 2011

Watson Pharmaceuticals is hoping to become the first company to market a generic treatment for cholesterol.

April 8, 2011

Watson announced that its subsidiary is seeking approval to market a generic version of a bacterial conjunctivitis treatment.

February 25, 2011

Watson Labs is hoping to be the first to market a generic version of a popular drug for attention deficit hyperactivity disorder.

January 31, 2011

Mylan has announced its intention to market a version of a painkiller made by Endo Pharmaceuticals and partner company Teikoku Seiyaku ahead of patent expiration.

January 28, 2011

The Food and Drug Administration has approved a generic hypertension treatment made by Mylan.

January 26, 2011

Watson Pharmaceuticals is seeking regulatory approval for a generic drug for high cholesterol.

January 4, 2011

Par Pharmaceutical has started shipping a generic version of a hypertension drug, the company said Monday.

January 4, 2011

Generic drug maker Par Pharmaceutical has begun shipping its version of a treatment for heart rhythm problems, the company said Monday.

December 15, 2010

Drug maker Watson Pharmaceuticals said it has filed a regulatory approval application for a generic painkiller, challenging the patent that covers the branded version.

November 29, 2010

Generic drug maker Impax Labs is challenging the patent covering a drug used to treat high cholesterol, the company said Friday.

November 15, 2010

Generic drug maker Actavis has filed for approval of a generic version of an antidepressant...

October 4, 2010

Ranbaxy has won the right to sell a generic version of an Alzheimer’s disease drug...

October 4, 2010

Generic drug maker Watson Pharmaceuticals is seeking approval for a generic treatment for Parkinson’s disease,...

September 9, 2010

This week’s decision by the U.S. Second Circuit Court of Appeals could make political efforts...

September 6, 2010

Generic drug maker Watson Pharmaceuticals has applied for Food and Drug Administration approval for a...

August 11, 2010

The main lobbying group for the generic drug industry said federal authorities erred in projecting...

June 13, 2010

Indian generic drug maker Lupin is challenging a Gilead Sciences patent for a drug that...

June 10, 2010

Sandoz has opened what it calls a key site for the development of generic drugs...

May 25, 2010

Generic drug maker Watson Pharmaceuticals is challenging the patent on a drug for treating kidney...